DS
TVGN icon

David Shaw’s Tevogen Inc TVGN Stock Holding History

David Shaw’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,923
Closed -$8.22M – 4933
2022
Q4 		$8.22M Hold
15,923
– – 0.01% 1618
2022
Q3 		$8.09M Buy
15,923
+5,099
+47% +$2.57M 0.01% 1545
2022
Q2 		$5.42M Buy
10,824
+2,144
+25% +$1.07M 0.01% 2025
2022
Q1 		$4.33M Buy
+8,680
New +$4.32M ﹤0.01% 2481

Other funds holding TVGN

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

David Shaw's TVGN Position: Q1 2023 in Review

David Shaw sold out of Tevogen Inc (TVGN) in Q1 2023, closing a stake of 15,923 shares — an estimated $8.22M sold.

David Shaw first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $8.22M in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

  • David Shaw reported no remaining Tevogen Inc position as of Q1 2023 after selling out during the quarter.
  • David Shaw sold 15,923 Tevogen Inc shares in Q1 2023, an estimated $8.22M.
  • David Shaw first reported a position in Tevogen Inc in Q1 2022 and held it in 4 quarters.
  • David Shaw's Tevogen Inc position peaked at $8.22M in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Tevogen Inc as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.